Clinical Trial Update: Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia Safety and Efficacy of Venetoclax With Escalating Doses of Omacetaxine in Patients With Acute Myeloid Leukemia (AML) [Phase 1]

View source ↗

Summary

Phase 1 study assessing the safety and preliminary efficacy of venetoclax with escalating doses of omacetaxine in patients with acute myeloid leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Synribo (omacetaxine mepesuccinate)
• Venclexta (venetoclax)

Snippet

Sponsor: University of Illinois at Chicago | Conditions: Relapsed or Refractory Hematologic Malignancies | Phase 1 | Status: COMPLETED